Kazmierczak & Nowak Dds Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 800 Delaware Rd, Kenmore, NY 14223 Phone: 716-877-5566 Fax: 716-877-9580 |
Good Neighbors Dental Group Pllc Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 959 Kenmore Ave, Kenmore, NY 14223 Phone: 716-871-1614 Fax: 716-871-1519 |
Edward D Long Iii Dds Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 1895 Sheridan Drive, Kenmore, NY 14223 Phone: 716-874-6363 Fax: 716-874-6700 |
Kenmore Dental Assoc. Llp Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2835 Elmwood Ave, Kenmore, NY 14217 Phone: 716-874-1826 Fax: 716-874-6226 |
Advantage Dentistry Dentist Medicare: Not Enrolled in Medicare Practice Location: 2887 Elmwood Ave, Kenmore, NY 14217 Phone: 716-877-2275 Fax: 716-447-9442 |
Hannonpiazzaddspllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 39 Delaware Rd, Kenmore, NY 14217 Phone: 716-874-9981 Fax: 716-873-5839 |
Herbert Simon Dds And Carol Simon Dds Partners Dentist Medicare: Not Enrolled in Medicare Practice Location: 2840 Delaware Avenue, 2nd Floor, Kenmore, NY 14217 Phone: 716-875-4295 Fax: 716-876-8237 |
News Archive
An analysis of diabetes trials worldwide has found they are not addressing key issues relating to the condition with almost two thirds focusing on drug therapy while only one in ten addresses prevention or behavioural therapies.
Researchers at the University of Rochester have designed a gene that produces a thousand times more protein in cancer cells than in healthy cells.
A compound tested by UT Southwestern Medical Center investigators destroys several viruses, including the deadly Spanish flu that killed an estimated 30 million people in the worldwide pandemic of 1918.
The transplantation of stem cells from a healthy donor (allogeneic) offers the chance of cure for patients with an aggressive form of chronic lymphocytic leukemia (CLL), irrespective of genetic prognostic factors and the prior course of the disease. The German CLL Study Group proved this in a multicentric clinical phase II study led by Professor Dr. Peter Dreger, senior consultant and head of the division of stem cell transplantation at the Department of Internal Medicine V at Heidelberg University Hospital.
Cambridge Heart, Inc., developer of non-invasive diagnostic tests for cardiac disease, today announced that on December 20, 2010 it completed a private placement to accredited investors. The transaction raised gross proceeds of $2.9 million and consisted of Units that were comprised of one share of common stock and a warrant to purchase one share of common stock.
› Verified 5 days ago